Mylan gains FDA nod for generic migraine therapy

05/17/2013 | Drug Store News

Mylan received federal approval for its zolmitriptan tablets in two strengths, 2.5 mg and 5 mg. The drug, which addresses acute migraine in adults, is a generic form of Zomig by IPR Pharmaceuticals.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI